Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Axon Therapies developed the SAVM procedure. Their novel approach to modulating the body’s sympathetic nervous system to restore balance in the circulatory system.

HUYA Bioscience enables and accelerates the global development of novel biopharmaceutical product opportunities. It identifies and licenses pre-clinical and clinical-stage compounds, then leverages and extends the research efforts of its partners and also provides a bridge into the international development process and global biopharma market while lowering risk, providing partner companies with an ensured and continuous source of compounds for the future. HUYA Bioscience was founded in 2004 and is headquartered in San Diego, California.

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany.

Fu Wai Hospital, founded in 1956.

Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Tongling Bionic Technology engages in the research and development of high-end medical devices. The production of minimally invasive catheter-type synchronous heart assists pumps for the treatment of patients with severe heart failure provides a simple and easy-to-use new tool for hospitals in the treatment of patients with severe heart failure and brings good news to the majority of patients with severe heart failure. The company has a talent team composed of more than 20 fixed scientific researchers and has a number of invention patents. The company's new-generation cardiac function assist device project is being developed in cooperation with Imperial College London, University of Science and Technology of China, Fuwai Hospital, Chinese Academy of Medical Sciences, National Fluid Machinery Engineering Technology Research Center, and Zhuhai Jindao Medical Materials Co., Ltd.

NANOSYSTEM engages in system development and outsourcing businesses.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Alkermes Pharma Ireland Ltd., part of Alkermes Plc, is a company headquartered in Athlone, Ireland. The firm develops and manufactures oral dosage products.

Pacesetter, Inc., a subsidiary of Abbott Laboratories, is a company headquartered in the United States that manufactures, and distributes cardiovascular and implantable neuro stimulation medical devices.

Part of BIOTRONIK SE & Co. KG, Biotronik AG is a Swiss company located in Bulach that manufactures devices for vascular intervention and electrotherapy of heart.\nThe company says this about itself: BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on 29 December 2006. The company was originally founded in 1851 by Ernst Christian Friedrich Schering. The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion. They retain the largest German manufacturing facility which is located in Bergkamen. The company focuses on the business areas of gynaecology and andrology, oncology, and also special therapeutics, diagnostical devices, and nuclear medicine. Schering's best-known product is their line of combined oral contraceptive pills. Through Bayer Healthcare AG, Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations.

Societal CDMO, Inc. is a bi-coastal contract development and manufacturing organization (CDMO), which engages in spanning pre-investigational new drug (IND) development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a focus on small molecules. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill and finish, lyophilization, packaging, and logistics services to the pharmaceutical market. The company was founded by Geraldine A. Henwood and Thomas F. Henwood on November 15, 2007 and is headquartered in Exton, PA.

Baudax Bio, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for acute care settings. The company was founded in 2015 and is headquartered in Malvern, PA.

Elan Pharma International Ltd., a subsidiary of Perrigo Co. Plc, is a company headquartered in South San Francisco, CA, that develops, manufactures and distributes pharmaceutical products.